Genomics AI

Genomics AI (operating legally as Genomai) is a precision oncology and bioinformatics company that develops an AI-powered genome analysis platform. The company's core technology functions as a digital molecular tumor board, integrating complex multi-omic data—including genomic variants, pathology reports, imaging studies, and clinical history—to provide real-time, evidence-based treatment recommendations and clinical trial matching for oncologists. The company specializes in the development of bioinformatics knowledge graphs and AI-driven clinical decision support systems. Its platform is designed to translate raw genetic data into actionable clinical insights, helping healthcare providers identify optimal treatment sequences, monitor resistance through ctDNA, and navigate the rapidly expanding landscape of oncology research and therapeutic options.